Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000921895-22-001874)

Filing Details

Accession Number:: 0000921895-22-001874
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2022-06-02 09:46:10
Reporting Period:: 2022-06-01

Accepted Time:: 2022-06-02 09:46:10
Original Submission Date:: 2022-06-02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1719406	Nrx Pharmaceuticals Inc.	NRXP	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1303782	C Jonathan Javitt	1201 North Market Street Suite 111 Wilmington DE 19801	Chief Scientist	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-06-01	100,000	$0.58	146,332	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	13,299,997	Indirect	By Trust
Common Stock	1,422,000	Indirect	By Trust

Footnotes

Reflects charitable donations of 49,000 shares of Common Stock that occurred in December 2021.
Held by the Jonathan Javitt Living Trust of which the Reporting Person is trustee.
Held by The Javitt 2012 Irrevocable Dynasty Trust of which the Reporting Person is the Grantor.